Scientific Session
Christina Charles-Schoeman, MD, MS
Professor of Medicine/Chief of the Division of Rheumatology
UCLA Medical Center
Santa Monica, California, United States
Disclosure(s): AbbVie/Abbott: Consultant (Ongoing), Grant/Research Support (Ongoing); Alexion: Grant/Research Support (Ongoing); Boehringer Ingelheim: Consultant (Ongoing); Bristol Myers Squibb: Consultant (Ongoing), Grant/Research Support (Ongoing); CSL Behring: Grant/Research Support (Ongoing); galapagos: Consultant (Ongoing); Janssen: Grant/Research Support (Ongoing); Octapharma: Consultant (Ongoing), Grant/Research Support (Ongoing); Pfizer: Consultant (Ongoing), Grant/Research Support (Ongoing); Priovant: Grant/Research Support (Ongoing); Recludix: Consultant (Ongoing)
Arthur Kavanaugh, MD
UCSD
La Jolla, California, United States
Disclosure(s): Amgen: Consultant (Ongoing); Bristol-Myers Squibb(BMS): Consultant (Ongoing); janssen: Consultant (Ongoing); Moonlake: Consultant (Ongoing); Pfizer: Consultant (Ongoing); UCB: Consultant (Ongoing)
Jeffrey Sparks, MD,MSc
Brigham and Women's Hospital
Boston, Massachusetts, United States
Disclosure(s): AbbVie/Abbott: Consultant (Ongoing); Boehringer-Ingelheim: Consultant (Ongoing), Grant/Research Support (Ongoing); Bristol-Myers Squibb(BMS): Consultant (Ongoing), Grant/Research Support (Ongoing)